MENU
MNKD
AS OF
Feb 4, 02:52 PM (EDT)
Price
$5.86
Change
-$0.35 (-5.64%)
Capitalization
1.91B
27 days until earnings call
Intraday BUY SELL Signals
+Compare
MNKD
Stock ticker: NASDAQ
AS OF
Feb 4, 02:52 PM (EDT)
Price
$5.86
Change
-$0.35 (-5.64%)
Capitalization
1.91B

MNKD MannKind Corp Forecast, Technical & Fundamental Analysis

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension... Show more

Industry: #Biotechnology
MNKD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MNKD with price predictions
Feb 03, 2026

MNKD in upward trend: 10-day moving average moved above 50-day moving average on February 02, 2026

The 10-day moving average for MNKD crossed bullishly above the 50-day moving average on February 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MNKD's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 28, 2026. You may want to consider a long position or call options on MNKD as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MNKD just turned positive on January 29, 2026. Looking at past instances where MNKD's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

MNKD moved above its 50-day moving average on January 28, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MNKD advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 175 cases where MNKD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNKD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MNKD broke above its upper Bollinger Band on February 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MNKD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (27.519). P/E Ratio (62.200) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (6.101) is also within normal values, averaging (331.843).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
MNKD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MNKD is expected to report earnings to fall 73.00% to 1 cents per share on March 03

MannKind Corp MNKD Stock Earnings Reports
Q4'25
Est.
$0.02
Q3'25
Beat
by $0.05
Q2'25
Est.
$0.05
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.05
The last earnings report on November 05 showed earnings per share of 7 cents, beating the estimate of 1 cents. With 790.90K shares outstanding, the current market capitalization sits at 1.91B.
A.I. Advisor
published General Information

General Information

a developer of therapeutic products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Casper Street
Phone
+1 818 661-5000
Employees
414
Web
https://www.mannkindcorp.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRLCX9.930.11
+1.12%
Hartford Real Asset C
VRTVX343.503.02
+0.89%
Vanguard Russell 2000 Value Index I
MVGKX17.850.01
+0.06%
MFS Low Volatility Global Equity R2
FDIVX51.66N/A
N/A
Fidelity Diversified International
CIVBX20.72-0.19
-0.91%
American Funds International Vntg 529-C

MNKD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with IONS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
+3.33%
IONS - MNKD
50%
Loosely correlated
+1.83%
VCYT - MNKD
44%
Loosely correlated
-1.10%
CYTK - MNKD
43%
Loosely correlated
-0.66%
INSM - MNKD
40%
Loosely correlated
+2.07%
DAWN - MNKD
39%
Loosely correlated
-2.96%
More